Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

A Randomized Phase II Study Evaluating the Efficacy and Safety of Deferasirox Versus Deferoxamine in Patients with Sickle Cell Disease (SCD): 2-Year Results Including Pharmacokinetics (PK) and Safety of Deferasirox with Concomitant Hydroxyurea Therapy

Elliott Vichinsky, MD, Marcela Torres, MD, Jonathan Glass, MD, Caterina P Minniti, MD, Stéphane Barrette, MD, Dany Habr, MD, Nicola Lynch, MS, Yiyun Zhang, Beatrice Files, MD

Blood (2011) 118 (21): 1082.

https://doi.org/10.1182/blood.V118.21.1082.1082

Published: 2011

Journal Articles

Novel Three- and Four-Drug Combination Regimens of Bortezomib, Dexamethasone, Cyclophosphamide, and Lenalidomide, for Previously Untreated Multiple Myeloma: Results From the Multi-Center, Randomized, Phase 2 EVOLUTION Study

Shaji Kumar, MD, Ian W. Flinn, MD, PhD, Paul G Richardson, MD, Parameswaran Hari, MD, Natalie Scott Callander, MD, Stephen J. Noga, MD, PhD, A. Keith Stewart, MD, Jonathan Glass, MD, FACP, Robert M. Rifkin, MD, Jeffrey L Wolf, MD, Jose Estevam, BS, George Mulligan, PhD, Hongliang Shi, MS, Iain J. Webb, MD, FRCPC, S. Vincent Rajkumar, MD

Blood (2010) 116 (21): 621.

https://doi.org/10.1182/blood.V116.21.621.621

Published: 2010

Journal Articles

Impact of Health Care Funding on overall Survival of Patients with Multiple Myeloma and Monoclonal Gammopathy of Uncertain Significance.

Srinivas S Devarakonda, MD, Binu S. Nair, MD, Ryan A. Gonzales, MD, Runhua Shi, MD, PhD, Nebu Koshy, MD, Gary Burton, MD, Jonathan Glass, MD, Francesco Turturro, MD

Blood (2010) 116 (21): 3821.

https://doi.org/10.1182/blood.V116.21.3821.3821

Published: 2010

Journal Articles

Phase 1/2 Clinical Trial of HQK-1001, An Oral Fetal Hemoglobin Stimulant, In Sickle Cell Anemia

Abdullah Kutlar, MD, Kenneth I. Ataga, MD, Marvin Reid, PhD, Loray A Blair-Britt, MD, Elliott Vichinsky, MD, Lynne Neumayr, MD, Richard J. Labotka, MD, MS, Jonathan Glass, MD, FACP, Andrea Small-WIlliams, MBBS, DM(HAEM), Jeffrey Keefer, MD, PhD, Ling Shen, MD, Michael S Boosalis, PhD, Audrey Thomson, BSc, Patrick Bobbitt, BS, Wayne Wallis, MD, Elsa Johnson, MBA, Ronald J Berenson, MD, Susan P Perrine, MD

Blood (2010) 116 (21): 943.

https://doi.org/10.1182/blood.V116.21.943.943

Published: 2010

Journal Articles

Therapeutic Response to Granulocyte Colony-Stimulating Factor in a Case of Selective IgA Deficiency (SIgAD) with Chronic Neutropenia.

Sarada Gummadi, MD, Jonathan Glass, MD

Blood (2009) 114 (22): 4512.

https://doi.org/10.1182/blood.V114.22.4512.4512

Published: 2009

Journal Articles

Safety and Efficacy of Novel Combination Therapy with Bortezomib, Dexamethasone, Cyclophosphamide, and Lenalidomide in Newly Diagnosed Multiple Myeloma: Initial Results from the Phase I/II Multi-Center EVOLUTION Study

Shaji Kumar, MD, Ian W Flinn, MD, PhD, Stephen J. Noga, MD, PhD, Parameswaran Hari, MD, MS, Robert M. Rifkin, MD, Natalie Scott Callander, MD, Manish Bhandari, MD, Jeffrey Lee Wolf, MD, Cristina Gasparetto, MD, Amrita Krishnan, MD, FACP, Daren D Grosman, MD, PhD, Jonathan Glass, MD, Entezam Asim Sahovic, MD, Hongliang Shi, MS, Iain J. Webb, MD, Paul Richardson, MD, S. Vincent Rajkumar, MD

Blood (2008) 112 (11): 93.

https://doi.org/10.1182/blood.V112.11.93.93

Published: 2008

Journal Articles

Inpatient Pharmaceutical Cost of Hematological Agents: A Single Center Report.

Charles V. Wendling, MD, Jonathan Glass, MD, Perry G. Rigby, MD

Blood (2006) 108 (11): 5491.

https://doi.org/10.1182/blood.V108.11.5491.5491

Published: 2006

Journal Articles

Therapeutic Dilemma of Chemotherapy Dosing in Morbidly Obese Patient with AML: A Case Report and a Review of the Literature.

Sakeer Hussain, MD, Jonathan Glass, MD, Oscar Ballester, MD

Blood (2006) 108 (11): 5534.

https://doi.org/10.1182/blood.V108.11.5534.5534

Published: 2006

Journal Articles

Protoporphyrin IX Down-Regulates DMT1 Associated Protein (DAP) in K562 Cells.

Yasumasa Okazaki, MD, PhD, Hong Yin, MD, PhD, Yuxiang Ma, MD, PhD, Mary Yeh, MS, Kwo-yih Yeh, PhD, Jonathan Glass, MD

Blood (2006) 108 (11): 1548.

https://doi.org/10.1182/blood.V108.11.1548.1548

Published: 2006

Journal Articles

The Interaction of MOZ-TIF2 with Histone Chaperon Proteins CAF-1A and Asf1b Alters MOZ Regulated Gene Expression.

Hong Yin, MD, PhD, Jonathan Glass, MD, Kerry L. Blanchard, MD, PhD

Blood (2006) 108 (11): 2208.

https://doi.org/10.1182/blood.V108.11.2208.2208

Published: 2006

Journal Articles

Iron Transport in Intestinal Epithelial Cells Occurs by Transcytosis. A Fluorescent Metal-Sensor Study.

Yuxiang Ma, MD, PhD, Mary Yeh, MS, Kwo-yih Yeh, PhD, Jonathan Glass, MD

Blood (2005) 106 (11): 3583.

https://doi.org/10.1182/blood.V106.11.3583.3583

Published: 2005

Journal Articles

The DMT1 Associated Protein (DAP) Regulates Iron Uptake by Erythroid Cells.

Jonathan Glass, MD, Yi Chen, PhD, Yuxiang Ma, MD, PhD, Mary Yeh, MS, Kwo-yih Yeh, PhD

Blood (2004) 104 (11): 53.

https://doi.org/10.1182/blood.V104.11.53.53

Published: 2004

Journal Articles

Troglitazone Exerts a Cell-Dependent Effect on the Extracellular Secretion of VEGF 165 Independently from the Rapamycin Sensitivity or the Level of eIF4E Expression in AML-Derived Cells.

Ellen Friday, PhD, Jonathan Glass, MD, Francesco Turturro, MD

Blood (2004) 104 (11): 4363.

https://doi.org/10.1182/blood.V104.11.4363.4363

Published: 2004

NARROW

A Randomized Phase II Study Evaluating the Efficacy and Safety of Deferasirox Versus Deferoxamine in Patients with Sickle Cell Disease (SCD): 2-Year Results Including Pharmacokinetics (PK) and Safety of Deferasirox with Concomitant Hydroxyurea Therapy

Novel Three- and Four-Drug Combination Regimens of Bortezomib, Dexamethasone, Cyclophosphamide, and Lenalidomide, for Previously Untreated Multiple Myeloma: Results From the Multi-Center, Randomized, Phase 2 EVOLUTION Study

Impact of Health Care Funding on overall Survival of Patients with Multiple Myeloma and Monoclonal Gammopathy of Uncertain Significance.

Phase 1/2 Clinical Trial of HQK-1001, An Oral Fetal Hemoglobin Stimulant, In Sickle Cell Anemia

Therapeutic Response to Granulocyte Colony-Stimulating Factor in a Case of Selective IgA Deficiency (SIgAD) with Chronic Neutropenia.

Safety and Efficacy of Novel Combination Therapy with Bortezomib, Dexamethasone, Cyclophosphamide, and Lenalidomide in Newly Diagnosed Multiple Myeloma: Initial Results from the Phase I/II Multi-Center EVOLUTION Study

Inpatient Pharmaceutical Cost of Hematological Agents: A Single Center Report.

Therapeutic Dilemma of Chemotherapy Dosing in Morbidly Obese Patient with AML: A Case Report and a Review of the Literature.

Protoporphyrin IX Down-Regulates DMT1 Associated Protein (DAP) in K562 Cells.

The Interaction of MOZ-TIF2 with Histone Chaperon Proteins CAF-1A and Asf1b Alters MOZ Regulated Gene Expression.

Iron Transport in Intestinal Epithelial Cells Occurs by Transcytosis. A Fluorescent Metal-Sensor Study.

The DMT1 Associated Protein (DAP) Regulates Iron Uptake by Erythroid Cells.

Troglitazone Exerts a Cell-Dependent Effect on the Extracellular Secretion of VEGF 165 Independently from the Rapamycin Sensitivity or the Level of eIF4E Expression in AML-Derived Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only